文献速递神经肿瘤

Notch通路在胶质母细胞瘤中的治疗靶向研究综述

Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
PubMed 文献 · World Neurosurg · 2019-07-31

本文综述2003年至2015年7月关于胶质母细胞瘤(GBM)与Notch受体的文献,最终纳入55篇。多数研究显示GBM细胞系中Notch活性表达升高,靶向Notch通路(基因敲低/过表达、配体及γ-分泌酶等)可改善恶性表型,提示其治疗潜力。

要点

  • 多数评估Notch活性的文章显示GBM细胞系中表达升高
  • 靶向Notch通路及配体、γ-分泌酶等可减弱GBM恶性特征
  • Notch活性与缺氧及PI3K/AKT/mTOR、ERK/MAPK通路相关

核心结论

  • 近期文献提示靶向Notch通路对GBM未来治疗具有较大潜力。

研究设计与样本

  • 文献检索2003年至2015年7月间含「Glioblastoma」与「Receptors, Notch」的文章,检索到62篇,46篇符合标准。
  • 另从其他来源纳入9篇,最终综述55篇。

主要发现

  • 55篇中47篇使用已建立的人GBM细胞系,17篇使用人GBM手术样本。
  • 靶向Notch通路的方式包括Notch敲低与过表达,以及靶向δ样配体、Jagged、γ-分泌酶、ADAM10、ADAM17和Mastermind样蛋白1。
  • 三氧化二砷、microRNA及若干其他化合物显示对GBM中Notch通路有影响。

关键数值与推荐

  • 标准治疗(切除、放疗、化疗)后5年生存率<5%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma (GBM) is the most common and deadly form of brain tumor. After standard treatment of resection, radiotherapy, and chemotherapy, the 5-year survival is <5%. In recent years, research has uncovered several potential targets within the Notch signaling pathway, which may lead to improved patient outcomes. METHODS: A literature search was performed for articles containing the terms "Glioblastoma" and "Receptors, Notch" between 2003 and July 2015. Of the 62 articles retrieved, 46 met our criteria and were included in our review. Nine articles were identified from other sources and were subsequently included, leaving 55 articles reviewed. RESULTS: Of the 55 articles reviewed, 47 used established human GBM cell lines. Seventeen articles used human GBM surgical samples. Forty-five of 48 articles that assessed Notch activity showed increased expression in GBM cell lines. Targeting the Notch pathway was carried out through Notch knockdown and overexpression and targeting δ-like ligand, Jagged, γ-secretase, ADAM10, ADAM17, and Mastermindlike protein 1. Arsenic trioxide, microRNAs, and several other compounds were shown to have an effect on the Notch pathway in GBM. Notch activity in GBM was also shown to be associated with hypoxia and certain cancer-related molecular pathways such as PI3K/AKT/mTOR and ERK/MAPK. Most articles concluded that Notch activity amplifies malignant characteristics in GBM and targeting this pathway can bring about amelioration of these effects. CONCLUSIONS: Recent literature suggests targeting the Notch pathway has great potential for future therapies for GBM.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gersey Z, Osiason AD, Bloom L, et al. Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme. World Neurosurg. 2019. PMID: 31376551. doi:10.1016/j.wneu.2019.07.180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。